LI
MYOV

Leap Investments’s Myovant Sciences Ltd. MYOV Stock Holding History

Leap Investments’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$371K Buy
18,000
+4,700
+35% +$63.9K 0.24% 152
2020
Q1 		$100K Sell
13,300
-12,234
-48% -$137K 0.15% 265
2019
Q4 		$396K Buy
25,534
+9,788
+62% +$98.7K 0.19% 195
2019
Q3 		$82K Sell
15,746
-10,764
-41% -$79.8K 0.04% 378
2019
Q2 		$240K Buy
+26,510
New +$395K 0.32% 124

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Leap Investments's MYOV Position: Q2 2020 in Review

Leap Investments increased its Myovant Sciences Ltd. (MYOV) stake by 35% in Q2 2020, buying an estimated $63.9K and bringing the position to 18,000 shares worth $371K. The position accounts for 0.24% of the portfolio, ranked #152.

Leap Investments first reported a position in MYOV in Q2 2019 and has held it in 5 quarters since. The position peaked at $396K in Q4 2019. 96 funds tracked by Wall St. Rank hold MYOV as of Q2 2020.

  • Leap Investments held 18,000 shares of Myovant Sciences Ltd. worth $371K as of Q2 2020.
  • Leap Investments bought 4,700 Myovant Sciences Ltd. shares in Q2 2020, an estimated $63.9K.
  • Myovant Sciences Ltd. made up 0.24% of Leap Investments's portfolio in Q2 2020, its #152 holding.
  • Leap Investments first reported a position in Myovant Sciences Ltd. in Q2 2019 and has held it in 5 quarters since.
  • Leap Investments's Myovant Sciences Ltd. position peaked at $396K in Q4 2019.
  • 96 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.